Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Saved in:
Bibliographic Details
Published in:Blood cancer journal (New York) Vol. 12; no. 4; pp. 51 - 4
Main Authors: Chang, Vicky C., Khan, Ali A., Huang, Wen-Yi, Katki, Hormuzd A., Purdue, Mark P., Landgren, Ola, Hofmann, Jonathan N.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-04-2022
Springer Nature B.V
Nature Publishing Group
Subjects:
692/308/174
692/499
692/699/67/1990/804
692/699/67/2324
Biomedical and Life Sciences
Biomedicine
Body Mass Index
Cancer Research
Clinical Trials as Topic
Colorectal Neoplasms
Correspondence
Early Detection of Cancer
Female
Hematology
Humans
Lung
Male
Monoclonal Gammopathy of Undetermined Significance - diagnosis
Monoclonal Gammopathy of Undetermined Significance - epidemiology
Multiple Myeloma - diagnosis
Multiple Myeloma - epidemiology
Oncology
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - epidemiology
Prostate
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:2044-5385
2044-5385
DOI:10.1038/s41408-022-00642-4